v2.4.0.8
Equity Method Investments and Joint Ventures (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Equity Method Investments And Joint Ventures [Abstract]    
Summarized Unaudited Financial Information

Summarized unaudited financial information for Ziopharm for the three and nine months ended September 30, 2013 and 2012 are as follows:

 

      Three months ended
September 30,
    Nine months ended
September 30,
 
     2013     2012     2013     2012  

 

 

Revenues

   $ 200      $ 200      $ 600      $ 600   

Operating expenses

     9,315        21,927        51,592        63,926   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (9,115     (21,727     (50,992     (63,326

Other

     (7,598     3,903        2,789        (2,581
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (16,713   $ (17,824   $ (48,203   $ (65,907

Summarized unaudited financial information for AquaBounty as of December 31, 2012 and for the period subsequent to the Company’s investment to December 31, 2012 is as follows:

 

      2012  

 

 

Current assets

   $ 514   

Non-current assets

     1,962   
  

 

 

 

Total assets

     2,476   

Current liabilities

     706   

Non-current liabilities

     2,741   
  

 

 

 

Total liabilities

     3,447   
  

 

 

 

Net liabilities

   $ (971

 

 

 

      2012  

 

 

Revenues

   $   

Operating expenses

     578   
  

 

 

 

Loss from operations

     (578

Other expense

     (1
  

 

 

 

Net loss

   $ (579